NCT00362752View on ClinicalTrials.gov

A Pilot Study of Norfloxacin for Hepatopulmonary Syndrome

PHASE2CompletedINTERVENTIONAL
Enrollment

9

Participants

Timeline

Start Date

October 31, 2006

Primary Completion Date

January 31, 2009

Study Completion Date

December 31, 2009

Conditions
Hepatopulmonary Syndrome
Interventions
DRUG

Norfloxacin

400 mg po bid

DRUG

Placebo

Placebo 400 mg po bid

Trial Locations (1)

M5B 1W8

St. Michael's Hospital, Toronto

All Listed Sponsors
collaborator

University of Toronto

OTHER

lead

Unity Health Toronto

OTHER

NCT00362752 - A Pilot Study of Norfloxacin for Hepatopulmonary Syndrome | Biotech Hunter | Biotech Hunter